159 related articles for article (PubMed ID: 6989376)
1. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
Fumex JP; Michel FB
Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
[No Abstract] [Full Text] [Related]
2. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
Charachon R; Lavillauroy PJ; Fumex JP
Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
Rossi S; Tazza R
Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
[No Abstract] [Full Text] [Related]
4. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulatory properties of ribosomal vaccine in the prevention of recurrent infections].
Gawlik R; Danek K
Przegl Lek; 2002; 59(6):450-2. PubMed ID: 12418285
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
Michel FB; d'Hinterland LD; Pinel AM; Guendon R; Guerrero A; Préault M
Nouv Presse Med; 1975 Feb; 4(5):333-6. PubMed ID: 1093123
[No Abstract] [Full Text] [Related]
7. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP
Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
Michel FB; Dussourd d'Hinterland L
Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
[No Abstract] [Full Text] [Related]
9. [Prevention of bacterial respiratory infections by ribosomal vaccines].
Michel FB; D'Hinterland LD; Fumex JP; Guendon R
Bronchopneumologie; 1979; 29(4):337-42. PubMed ID: 509335
[No Abstract] [Full Text] [Related]
10. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
[TBL] [Abstract][Full Text] [Related]
11. [Respiratory-tract-directed immunostimulation by a vaccine administered by the oral route].
Menardo JL; Bousquet J; Clavel R; Coulet P; Michel FB
Poumon Coeur; 1982; 38(5):297-300. PubMed ID: 7156001
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic bronchopulmonary infections].
Popescu C; Meitert E; Russ R; Meitert T; Sima F; Savulian C; Esrig E
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):261-72. PubMed ID: 6318298
[No Abstract] [Full Text] [Related]
13. Vaccinology in the prophylaxis of respiratory infections--Part II.
Griffin JP
Clin Notes Respir Dis; 1978; 17(2):3-12. PubMed ID: 699411
[No Abstract] [Full Text] [Related]
14. [Biostim prevention of recurrent respiratory infections in children. A double-blind versus placebo study].
Paupe J; Paupe G
Ann Pediatr (Paris); 1986 Nov; 33(9):843-5. PubMed ID: 3541764
[No Abstract] [Full Text] [Related]
15. The usefulness of transfer factor in asthma associated with frequent infections.
Khan A; Sellars W; Grater W; Graham MF; Pflanzer J; Antonetti A; Bailey J; Hill NO
Ann Allergy; 1978 Apr; 40(4):229-32. PubMed ID: 345886
[TBL] [Abstract][Full Text] [Related]
16. [Controlled trial of a polyvalent antibacterial vaccine in children with recurrent respiratory infections].
Milano C; Di Fazio A; Bellioni P; Stella A; Aiuti F; Businco L
Minerva Pediatr; 1980 May; 32(9):641-6. PubMed ID: 7007861
[No Abstract] [Full Text] [Related]
17. [Immunotherapy of chronic inflammatory and allergic-inflammatory respiratory tract diseases - a current problem].
Hałasa J
Pol Tyg Lek; 1981 Apr; 36(15):535-6. PubMed ID: 7024942
[No Abstract] [Full Text] [Related]
18. [The role of various forms of ribomunyl in recurrent respiratory tract infections].
Girard JP; Gumowski PI; Chavaz A; Lech B
Schweiz Med Wochenschr; 1988 Jun; 118(22):856-61. PubMed ID: 3291110
[TBL] [Abstract][Full Text] [Related]
19. An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis.
Davies MG; Symons C; Shaw S; Kaminski ER
J Dermatolog Treat; 2006; 17(2):74-7. PubMed ID: 16766329
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotics in respiratory tract infections. Enormous differences in compliance].
MMW Fortschr Med; 2001 Dec; 143(51-52):50-1. PubMed ID: 11824169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
